UBS Group’s GoodRx Holdings GDRX Stock Holding History

UBS Group’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-45,400	Closed	-$354K	–	9698
2024 Q2	$354K	Sell	45,400 -15,500	-25%	-$115K	﹤0.01%	5260
2024 Q1	$432K	Buy	60,900 +12,900	+27%	+$85.3K	﹤0.01%	5319
2023 Q4	$322K	Buy	+48,000	New	+$270K	﹤0.01%	5447
2023 Q1	–	Sell	-300,000	Closed	-$1.4M	–	9858
2022 Q4	$1.4M	Buy	+300,000	New	+$1.48M	﹤0.01%	3749
2022 Q2	–	Sell	-205,000	Closed	-$3.96M	–	10535
2022 Q1	$3.96M	Buy	205,000 +200,000	+4,000%	+$4.59M	﹤0.01%	2769
2021 Q4	$163K	Sell	5,000 -260,000	-98%	-$10.5M	﹤0.01%	5865
2021 Q3	$10.9M	Buy	265,000 +75,000	+39%	+$2.72M	﹤0.01%	1963
2021 Q2	$6.84M	Buy	190,000 +25,000	+15%	+$923K	﹤0.01%	2375
2021 Q1	$6.44M	Buy	165,000 +155,800	+1,693%	+$7.01M	﹤0.01%	2345
2020 Q4	$371K	Buy	+9,200	New	+$423K	﹤0.01%	4834

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

UBS Group's GDRX Position: Q1 2026 in Review

UBS Group increased its GoodRx Holdings (GDRX) stake by 24% in Q1 2026, buying an estimated $374K and bringing the position to 826,912 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #5162.

UBS Group first reported a position in GDRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $37.2M in Q1 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

UBS Group held 826,912 shares of GoodRx Holdings worth $1.62M as of Q1 2026.
UBS Group bought 159,465 GoodRx Holdings shares in Q1 2026, an estimated $374K.
GoodRx Holdings made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5162 holding.
UBS Group first reported a position in GoodRx Holdings in Q3 2020 and has held it in 23 quarters since.
UBS Group's GoodRx Holdings position peaked at $37.2M in Q1 2021.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.